i did notice the thread was very quiet with 4 or 5 long term holders. Chairmans update caught my attention last week & pushed me to look further.
Very exciting with such large libraries of diverse peptides under their control & the high level of interest from some of the largest pharmas in the world.
All backed by a very favourable business model.
PYC does seem very unnoticed & unloved where it is but highly encouraging that the majority of the listed securities are held firmly in the Top 20. I have had a pretty good look over all the devlopments of the past 18 or so months & the update does look like they're very close to stepping into the high return phase.
I take it from the recent update Roche's next move & an entirley new partnership are are on the cards in the very near future.
FWIW - Roche partnership was signed 12 months from this Saturday if they like keeping things within a year.....
PYC Price at posting:
4.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)